Investigating the clinical utility of biomarkers and other novel tests in younger onset neurocognitive disorders: the BeYOND study, protocol for a longitudinal clinical study in a real-world setting

Samantha M Loi, Dhamidhu Eratne, Claire Cadwallader, Parsa Ravanfar, Carolyn Chadunow, Lesley Vidaurre, Sarah Farrand, Wendy Kelso, Anita MY Goh, Rosie Watson, Andrew Evans, Mark Walterfang, Dennis Velakoulis
doi: https://doi.org/10.1101/2021.07.03.21259825

Article usage

Article usage: July 2021 to August 2025

AbstractFullPdf
Jul 2021678767
Aug 2021931212
Sep 202155218
Oct 20214348
Nov 202142717
Dec 20214104
Jan 20222173
Feb 20222934
Mar 20222624
Apr 20224007
May 202221111
Jun 20223018
Jul 20222810
Aug 20223118
Sep 202240211
Oct 20223707
Nov 20222605
Dec 20221516
Jan 20232324
Feb 20231432
Mar 20231420
Apr 20232345
May 20231443
Jun 2023851
Jul 20231332
Aug 202314124
Sep 20231153
Oct 2023541
Nov 20237010
Dec 2023912
Jan 20241428
Feb 20242489
Mar 2024738
Apr 20241264
May 20241036
Jun 20241035
Jul 2024815
Aug 20241138
Sep 20242039
Oct 2024827
Nov 20247311
Dec 202412185
Jan 202591019
Feb 20255161
Mar 2025131011
Apr 202515106
May 2025161313
Jun 2025182011
Jul 2025181315
Aug 2025337
Back to top
Posted July 07, 2021.
Download PDF
Data/Code
Email
Investigating the clinical utility of biomarkers and other novel tests in younger onset neurocognitive disorders: the BeYOND study, protocol for a longitudinal clinical study in a real-world setting
Samantha M Loi, Dhamidhu Eratne, Claire Cadwallader, Parsa Ravanfar, Carolyn Chadunow, Lesley Vidaurre, Sarah Farrand, Wendy Kelso, Anita MY Goh, Rosie Watson, Andrew Evans, Mark Walterfang, Dennis Velakoulis
medRxiv 2021.07.03.21259825; doi: https://doi.org/10.1101/2021.07.03.21259825
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area